CrushSCI.com
提供学术论文选刊润色服务
Blood Cancer Journal 期刊封面 医学
返回期刊列表

Review Cycle Records

Blood Cancer Journal

Springer SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
96.4平均天数
86中位天数
19最短天数
203最长天数
2272025发文量

Paper Review Records

全部论文审稿周期

17 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

114 天

A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma

作者Ricardo Ahrens; Kyra Ahrens; Maximilian Al-Bazaz; Lisa Leypoldt; Carsten Bokemeyer; Winfried Alsdorf; Katja Weisel

作者单位1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Knowledge Technology Group, Department of Informatics, University of Hamburg, Hamburg, Germany

PDF源文件 DOI 网页
79 天

Clinicomolecular features and clonal evolution of KMT2A -PTD AML: prognostic impact of concurrent FLT3 -ITD under 2022 ELN risk stratification

作者Yi-Tsung Yang; Chi-Yuan Yao; Yong-Huai Yi; Chein-Jun Kao; Yuan-Yeh Kuo; Ming-En Lin; Hsin-An Hou; Chien-Chin Lin; Wen-Chien Chou; Hwei-Fang Tien

作者单位1. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 2. Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 3. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4. Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan; 5. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; 6. Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwan

PDF源文件 DOI 网页
116 天

Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma

作者Mansi R. Shah; Aishee Bag; Asis Shrestha; Yetunde Ogunsesan; Anup Trikannad; Sruthi Vellanki; Sanjay Muttineni; Hira Cheema; Syed Naqvi; Sasya Dronavalli; Samer Al Hadidi; Sharmilan Thanendrarjan; Maurizio Zangari; Frits van Rhee; Aniko Szabo; Rajshekar Chakraborty; Meera Mohan; Carolina Schinke

作者单位1. Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, USA; 2. Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA; 3. University of Arkansas for Medical Sciences, Myeloma Center, Little Rock, USA; 4. Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, USA; 5. Myeloma, Waldenstrom’s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, USA; 6. Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, USA; 7. Division of Division of Hematology Oncology, Columbia University Irving Medical Center, New York, USA; 8. Division of Lymphoma and Myeloma, University of Texas MD Anderson Cancer, Houston, USA

PDF源文件 DOI 网页
139 天

Persistence of M-proteins detected by mass spectrometry

作者David L. Murray; Jonathan Coker; Taxiarchis Kourelis; Angela Dispenzieri; Mindy Kohlhagen; Surendra Dasari; Maria Willrich

作者单位1. Division of Clinical Biochemistry & Immunology, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, USA; 2. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, USA; 3. Division of Quantitative Health Sciences, Mayo Clinic, Rochester, USA

PDF源文件 DOI 网页
54 天

Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

作者Alexandra D. Dreyfuss; Joachim Yahalom; Sridevi Rajeeve; Alexander M. Lesokhin; Gunjan L. Shah; Heather J. Landau; Maximilian Merz; Michael Scordo; Andriy Derkach; David Nemirovsky; Harper Hubbeling; Gustav Cederquist; Zachary R. Moore; Sergio A. Giralt; Sham Mailankody; Saad Z. Usmani; Brandon S. Imber; Hamza Hashmi

作者单位1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; 2. Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA; 3. Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 4. Division of Epidemiology and Biostatistics, Department of Research, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA

PDF源文件 DOI 网页
76 天

Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia

作者Mahnoor Fatima; Sudhesh Kumar; Momna Warraich; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat

作者单位1. Division of Hematology, Mayo Clinic, Rochester, USA; 2. Division of Hematology, Mayo Clinic, Jacksonville, USA; 3. Division of Hematology, Mayo Clinic, Scottsdale, USA

PDF源文件 DOI 网页
86 天

Patterns and perceptions of supplement use among patients with plasma cell disorders

作者Maria A. Malik; Eliana Schach; Yan Leyfman; Andriy Derkach; Francesca Castro; Jorge Arturo Hurtado Martinez; Ana M. Sahagun Sanchez Aldana; Patricia Alejandra Flores Perez; Jennifer M. Ahlstrom; Jay R. Hydren; Saad Z. Usmani; Jun J. Mao; Susan Chimonas; Urvi A. Shah

作者单位1. Department of Medicine, NYU Grossman School of Medicine, New York, USA; 2. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA; 3. Department of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA; 4. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 6. HealthTree Foundation, Lehi, USA; 7. Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA; 8. Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, USA

PDF源文件 DOI 网页
82 天

Dynamics of in vivo immune remodeling in Ph + all patients receiving frontline ponatinib and blinatumomab therapy

作者Nadia Peragine; Michela Ansuinelli; Giulia Radice; Mariangela Di Trani; Maria Stefania De Propris; Giada Almici; Marina Parisi; Maria Paola Martelli; Daniele Mattei; Erika Borlenghi; Federico Fazio; Daniele Vallisa; Sabina Chiaretti; Anna Guarini; Robin Foà

作者单位1. Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy; 2. Division of Hematology and Bone Marrow Transplant, Azienda Ospedaliera-Universitaria (AOU) Policlinico-S. Marco, Catania, Italy; 3. Dipartimento di Medicina e Chirurgia, Università di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy; 4. Division of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy; 5. Hematology, ASST Spedali Civili, Brescia, Italy; 6. Hematology, Azienda Ospedaliera-Universitaria SS. Arrigo e Biagio e Cesare Arrigo, Alessandria, Italy; 7. Hematology Unit, Department of Oncology and Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy

PDF源文件 DOI 网页
80 天

Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms

作者Ferran Balbastre-Úbeda; Sara Torres-Esquius; Maria Gabarrós-Subirà; Francisco Beas; Jordi Leno-Colorado; Cristina Sanchez-Morales; Tzu Hua Chen-Liang; Susana Urban-Giral; Meritxell Tena-Alegre; Ana María Hurtado; María Jesús Casas-Tio; Ana María Garrido; Pamela Acha; Adoración Blanco; Francesc Solé; Mónica Del Rey; María Díez-Campelo; David Valcárcel; Maria Julia Montoro; Andrés Jerez

作者单位1. Myeloid Malignancies Research Group, Vall d’Hebron Institute of Oncology (VHIO), Hematology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 2. Clinical and Molecular Genetics Area, Vall d’Hebron Hospital Medicine Genetics Group, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain; 3. Hematology Department, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Murcia, Spain; 4. Group of Genetics, Molecular Pathology and Rare Diseases, Health Sciences Faculty, Universidad Católica de Murcia, Guadalupe, Spain; 5. MDS Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Badalona, Spain; 6. Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

PDF源文件 DOI 网页
109 天

Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity

作者Kenneth JC Lim; Melinda Tan; Ricardo Parrondo; Saurabh Chhabra; Christoph Schaefers; Katharine Dooley; Andre De Menezes Silva Corraes; Malvika Gupta; Darin Carabenciov; Morie Gertz; Lisa Hwa; Stephens Haily; Prashant Kapoor; Taxiarchis Kourelis; Rahma Warsame; Joselle Cook; Moritz Binder; Nadine Abdallah; Saurabh Zanwar; P. Leif Bergsagel; Udit Yadav; Erin Wiedmeier-Nutor; Susan Geyer; Sikander Ailawadhi; Rafael Fonseca; Shaji Kumar; Anastasia Zekeridou; Yi Lin

作者单位1. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, USA; 2. Australian Centre for Blood Diseases, Monash University, Melbourne, Australia; 3. Department of Haematology, The Alfred Hospital, Melbourne, Australia; 4. Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, USA; 5. Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, USA; 6. Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic College of Medicine, Rochester, USA

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。